Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin Add-on for Eating Disorders
NCT05865288Phase 1Unknown
- Sponsor
- Shalvata Mental Health Center
- Start
- Jun 2023
- Primary completion
- Apr 2024
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxytocin nasal spray in eating disorders (2 arms), sponsored by Shalvata Mental Health Center. Primary endpoint: Eating Disorder Examination Questionnaire (EDEQ) at 6 weeks. Status: unknown.
02
Drugs
oxytocin nasal spray
03
Conditions
eating disorders
Beyond the preview
Go deeper on NCT05865288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05865288.